CDK-IN-2 is primarily utilized in research settings to study the role of cyclin-dependent kinases (CDKs) in cellular processes. It serves as a potent inhibitor of CDKs, which are crucial regulators of the cell cycle. By inhibiting these kinases, researchers can investigate the effects of cell cycle disruption on cancer cell proliferation, apoptosis, and other cellular functions. This compound is particularly valuable in preclinical studies aimed at understanding the mechanisms of CDKs in tumor growth and in the development of potential cancer therapies. Additionally, it aids in exploring the therapeutic potential of CDK inhibition in various diseases beyond oncology, such as neurodegenerative disorders and viral infections.